• 1. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. An ATP-selective, lanthanide complex luminescent probe?
  Xiao Liu,Jun Xu,Yinyun Lv,Wenyu Wu,Weisheng Liu,Yu Tang Dalton Trans., 2013,42, 9840-9846
• 4. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 5. Aggregation-induced emission enhancement of carbon quantum dots and applications in light emitting devices
  Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

Methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate (CAS No. 79685-41-9): A Key Intermediate in Modern Pharmaceutical Synthesis

Methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate, identified by its CAS number 79685-41-9, is a highly versatile and significant intermediate in the realm of pharmaceutical synthesis. This compound, characterized by its pyrimidine core structure, has garnered considerable attention due to its utility in the development of various therapeutic agents. The presence of both chloro and methanesulfonyl substituents makes it a valuable building block for further chemical modifications, enabling the synthesis of complex molecules with high precision and efficiency.

The structural attributes of methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate contribute to its broad applicability in medicinal chemistry. The chloro group at the 5-position and the methanesulfonyl group at the 2-position provide reactive sites that can be selectively modified through various coupling reactions, such as nucleophilic substitution and condensation reactions. These reactions are pivotal in constructing biaryl structures, which are prevalent in many pharmacologically active compounds.

In recent years, there has been a surge in research focused on developing novel antiviral and anticancer agents. The pyrimidine scaffold, a fundamental component of nucleic acids, has been extensively explored for its potential in drug design. Methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate plays a crucial role in this context, serving as a precursor for synthesizing pyrimidine-based inhibitors that target specific enzymes and pathways involved in viral replication and tumor growth. For instance, studies have demonstrated its utility in generating inhibitors of thymidylate synthase, an enzyme essential for DNA synthesis in both normal and cancer cells.

The methanesulfonyl group in methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate also contributes to its reactivity, allowing for further functionalization through reduction or hydrolysis to yield carboxylic acid or sulfonic acid derivatives. These derivatives can then be incorporated into more complex molecules through amide or ester bond formations, expanding the synthetic possibilities for drug development. The chloro group, on the other hand, can be displaced by a variety of nucleophiles, including amines and thiols, facilitating the introduction of diverse pharmacophores.

Advances in synthetic methodologies have further enhanced the utility of methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate. Modern techniques such as palladium-catalyzed cross-coupling reactions have enabled the introduction of aryl or heteroaryl groups at specific positions within the pyrimidine ring. This has opened up new avenues for designing molecules with enhanced binding affinity and selectivity. Additionally, flow chemistry approaches have been employed to streamline the synthesis of this intermediate, improving yield and scalability while reducing reaction times.

The pharmaceutical industry has also embraced green chemistry principles in the synthesis of methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate. Efforts have been directed towards minimizing waste generation and reducing the use of hazardous reagents. Solvent-free conditions and catalytic amounts of transition metals have been explored to achieve efficient transformations. These sustainable practices not only align with environmental regulations but also enhance cost-effectiveness by reducing purification steps and improving overall atom economy.

Recent studies have highlighted the potential of methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate in developing next-generation therapeutics. For example, researchers have utilized this compound to synthesize novel kinase inhibitors that target aberrantly activated signaling pathways in cancer cells. By modulating these pathways, these inhibitors can induce apoptosis or inhibit cell proliferation without affecting normal cells. The pyrimidine core serves as a privileged scaffold that allows for fine-tuning of physicochemical properties such as solubility and metabolic stability, crucial factors for drug-like characteristics.

In conclusion, methyl 5-chloro-2-methanesulfonylpyrimidine-4-carboxylate (CAS No. 79685-41-9) is an indispensable intermediate in modern pharmaceutical synthesis. Its unique structural features enable diverse chemical modifications, making it a valuable tool for developing antiviral, anticancer, and other therapeutic agents. With ongoing advancements in synthetic chemistry and green chemistry practices, this compound continues to play a pivotal role in innovation within the pharmaceutical industry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)